Can robotic surgery better preserve sensory function?: The significance and strategy of nerve preservation in axillary lymph node dissection.

Q Qiwen Liu (The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China) Z Zongyan Li Y Yueyue Teng (The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China) Y Yongxin Wu (The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China) X Xiaoyan Fu J Jing Cheng Y Yu Chen Z Zhijie Wu (Genecradle Therapeutics, Beijing) Z Ze Huang (The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China) L Lina Wei H Haiyan Li (School of Chemical Engineering and Technology)

Abstract

582 Background: Conventional axillary lymph node dissection (C-ALND) carries a high risk of damaging the intercostobrachial nerve (ICBN), which remains a critical clinical issue affecting both psychological recovery and quality of life in breast cancer patients. While advancements in minimally invasive surgery provide improved visualization and precision, evidence supporting its clinical benefit in preserving sensory function is lacking. Methods: A retrospective analysis was conducted on breast cancer patients who underwent robotic-assisted axillary lymph node dissection (R-ALND, n = 53) and endoscopic-assisted axillary lymph node dissection (E-ALND, n = 58) between 2021 and 2025 (total n = 111). The anatomical integrity of the ICBN (T1-3) was systematically identified and recorded during surgery. Additionally, a blinded evaluator performed standardized bedside sensory testing (BST) on four key ICBN areas (medial upper arm, axilla, upper chest, and lateral chest wall) three months postoperatively, using a scoring system adapted from the ISCIPS consensus group for the current study. A multivariate linear regression model was applied for analysis. Results: Compared with E-ALND, R-ALND demonstrated a significantly higher ICBN-trunk preservation rate (77.4% vs. 63.1%, p = 0.033) and a greater proportion of areas with normal sensation at three months postoperatively (89.2% vs. 74.6%, p = 0.025). Multivariate linear regression revealed that T2-ICBN trunk preservation was the strongest independent predictor of sensory recovery at three months (β = 0.571, 95% CI 0.477–0.664, P < 0.001), with an effect size (standardized β = 0.720) far exceeding other factors. Patients with T2-ICBN preservation achieved a 77.4% rate of completely normal sensation across all four key ICBN areas at three months. After adjusting for variables including T2-ICBN preservation, tumor stage, age and so on, robotic surgery showed a tendency to be an independent protective factor for sensory recovery at 3 months postoperatively compared with endoscopic surgery. (β = 0.110, p = 0.016). Conclusions: Through three-dimensional visualization and tremor-filtering technology, R-ALND significantly reduces the risk of iatrogenic ICBN injury and outperforms E-ALND in preserving short-term postoperative sensory function recovery. In the early phase with a limited learning curve, preserving the ICBN trunk (particularly the T2-ICBN) is recommended to retain most of the patient's sensory function.

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
Pages 582-582
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (11)

Q

Qiwen Liu

The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

Z

Zongyan Li

Y

Yueyue Teng

The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

Y

Yongxin Wu

The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

X

Xiaoyan Fu

J

Jing Cheng

Y

Yu Chen

Z

Zhijie Wu

Genecradle Therapeutics, Beijing

Z

Ze Huang

The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

L

Lina Wei

H

Haiyan Li

School of Chemical Engineering and Technology